Cencora, Inc.
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 15/3019% above fair value
$339.09−2.16 (-0.63%)
Close on Nov 20, 2026Market cap $64.71BP/E 25.2Yield 0.65%
Cencora Option Care Health (OPCH) by Quarter
Option Care Health (OPCH) — Consolidated GAAP Operating Income ($M) ($M)
Cencora Option Care Health (OPCH): $85.1M in Q3 FY26, up 2.9% from a year earlier. That is the highest of the 52 quarters on record here.
Latest, Q3 FY26
85.1
Period ended Jun 30, 2026 (CQ2 2026)
Change on a year earlier
+2.9%
82.7 in Q3 FY25
History
52 quarters
Since Q4 FY08
Sources
1
SEC EDGAR XBRL CompanyFacts (OPCH)
Where the Q3 FY26 figure comes from
“OPCH us-gaap:OperatingIncomeLoss = $85,140,000 (2026-04-01 to 2026-06-30)”
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Option Care Health (OPCH) — Consolidated GAAP Operating Income ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 FY26CQ2 2026 | Jun 30, 2026 | 85.1 | +2.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY26CQ1 2026 | Mar 31, 2026 | 72.5 | -8.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY25CQ3 2025 | Sep 30, 2025 | 84.5 | -0.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY25CQ2 2025 | Jun 30, 2025 | 82.7 | +2.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY25CQ1 2025 | Mar 31, 2025 | 79.2 | +14.8% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY24CQ3 2024 | Sep 30, 2024 | 85.1 | +5.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY24CQ2 2024 | Jun 30, 2024 | 80.7 | -2.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY24CQ1 2024 | Mar 31, 2024 | 69 | +3.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY23CQ3 2023 | Sep 30, 2023 | 81 | +33.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY23CQ2 2023 | Jun 30, 2023 | 82.4 | +39.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY23CQ1 2023 | Mar 31, 2023 | 66.6 | +27.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY22CQ3 2022 | Sep 30, 2022 | 60.7 | +14.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY22CQ2 2022 | Jun 30, 2022 | 59.1 | +22.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY22CQ1 2022 | Mar 31, 2022 | 52.2 | +79.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY21CQ3 2021 | Sep 30, 2021 | 52.9 | +52.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY21CQ2 2021 | Jun 30, 2021 | 48.1 | +107.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY21CQ1 2021 | Mar 31, 2021 | 29.1 | +238.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY21CQ4 2020 | Dec 31, 2020 | 44.3 | +216.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY20CQ3 2020 | Sep 30, 2020 | 34.6 | -395.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY20CQ2 2020 | Jun 30, 2020 | 23.2 | -390.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY20CQ1 2020 | Mar 31, 2020 | 8.60 | +59.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY20CQ4 2019 | Dec 31, 2019 | 14 | +3.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY19CQ3 2019 | Sep 30, 2019 | -11.7 | -191.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY19CQ2 2019 | Jun 30, 2019 | -8 | -189.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY19CQ1 2019 | Mar 31, 2019 | 5.40 | +74.2% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY19CQ4 2018 | Dec 31, 2018 | 13.5 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY18CQ3 2018 | Sep 30, 2018 | 12.8 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY18CQ2 2018 | Jun 30, 2018 | 8.90 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY18CQ1 2018 | Mar 31, 2018 | 3.10 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY16CQ1 2016 | Mar 31, 2016 | -1.30 | -79.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY15CQ3 2015 | Sep 30, 2015 | -19.3 | -30.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY15CQ2 2015 | Jun 30, 2015 | -254 | +3,868.8% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY15CQ1 2015 | Mar 31, 2015 | -6.20 | -45.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY14CQ3 2014 | Sep 30, 2014 | -27.7 | +3,857.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY14CQ2 2014 | Jun 30, 2014 | -6.40 | +146.2% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY14CQ1 2014 | Mar 31, 2014 | -11.3 | +413.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY13CQ3 2013 | Sep 30, 2013 | -0.70 | -120.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY13CQ2 2013 | Jun 30, 2013 | -2.60 | -196.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY13CQ1 2013 | Mar 31, 2013 | -2.20 | -155.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY12CQ3 2012 | Sep 30, 2012 | 3.40 | -20.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY12CQ2 2012 | Jun 30, 2012 | 2.70 | -40.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY12CQ1 2012 | Mar 31, 2012 | 4 | -23.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY11CQ3 2011 | Sep 30, 2011 | 4.30 | -64.8% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY11CQ2 2011 | Jun 30, 2011 | 4.50 | -66.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY11CQ1 2011 | Mar 31, 2011 | 5.20 | -182.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY10CQ3 2010 | Sep 30, 2010 | 12.2 | +82.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY10CQ2 2010 | Jun 30, 2010 | 13.5 | +159.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY10CQ1 2010 | Mar 31, 2010 | -6.30 | -246.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY09CQ3 2009 | Sep 30, 2009 | 6.70 | +139.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY09CQ2 2009 | Jun 30, 2009 | 5.20 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY09CQ1 2009 | Mar 31, 2009 | 4.30 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY08CQ3 2008 | Sep 30, 2008 | 2.80 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
Cite this data
StockData. (2026). Cencora Option Care Health (OPCH) ($M), quarterly Q4 FY08–Q3 FY26 [Data set]. Compiled from Cencora SEC filings and investor materials. https://stockdatahq.com/stocks/cor/kpis/peer-opch-opinc
See every metric in the Cencora KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?